97 related articles for article (PubMed ID: 35598237)
1. Evaluation of the
Murali M; Nair B; Radhakrishnan VV; Presanna AT; Nath LR
Comb Chem High Throughput Screen; 2023; 26(2):436-447. PubMed ID: 35598237
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: an in silico and in vitro approach.
Murali M; Nair B; Vishnu VR; Aneesh TP; Nath LR
Mol Divers; 2023 Oct; 27(5):2353-2363. PubMed ID: 36357813
[TBL] [Abstract][Full Text] [Related]
3. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[TBL] [Abstract][Full Text] [Related]
4. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
5. Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19.
Balkrishna A; Mittal R; Arya V
Curr Pharm Biotechnol; 2021; 22(10):1350-1359. PubMed ID: 33176643
[TBL] [Abstract][Full Text] [Related]
6. Promising inhibitors against main protease of SARS CoV-2 from medicinal plants:
Ebenezer O; Shapi M
Acta Pharm; 2022 Jun; 72(2):159-169. PubMed ID: 36651513
[TBL] [Abstract][Full Text] [Related]
7. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
8. Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking.
Wang WX; Zhang YR; Luo SY; Zhang YS; Zhang Y; Tang C
Nat Prod Res; 2022 May; 36(10):2580-2584. PubMed ID: 33769143
[TBL] [Abstract][Full Text] [Related]
9. Apigenin analogues as SARS-CoV-2 main protease inhibitors:
Farhat A; Ben Hlima H; Khemakhem B; Ben Halima Y; Michaud P; Abdelkafi S; Fendri I
Bioengineered; 2022 Feb; 13(2):3350-3361. PubMed ID: 35048792
[TBL] [Abstract][Full Text] [Related]
10. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
[TBL] [Abstract][Full Text] [Related]
11. Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies.
Murali M; Gowtham HG; Shilpa N; Krishnappa HKN; Ledesma AE; Jain AS; Shati AA; Alfaifi MY; Elbehairi SEI; Achar RR; Silina E; Stupin V; Ortega-Castro J; Frau J; Flores-Holguín N; Amruthesh KN; Shivamallu C; Kollur SP; Glossman-Mitnik D
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500380
[TBL] [Abstract][Full Text] [Related]
12. Molecular modelling identification of phytocompounds from selected African botanicals as promising therapeutics against druggable human host cell targets of SARS-CoV-2.
Uhomoibhi JO; Shode FO; Idowu KA; Sabiu S
J Mol Graph Model; 2022 Jul; 114():108185. PubMed ID: 35430474
[TBL] [Abstract][Full Text] [Related]
13. A threefold approach including quantum chemical, molecular docking and molecular dynamic studies to explore the natural compounds from Centaurea jacea as the potential inhibitors for COVID-19.
Muhammad S; Maqbool MF; Al-Sehemi AG; Iqbal A; Khan M; Ullah S; Khan MT
Braz J Biol; 2021; 83():e247604. PubMed ID: 34495156
[TBL] [Abstract][Full Text] [Related]
14. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2.
Erol I; Kotil SE; Fidan O; Yetiman AE; Durdagi S; Ortakci F
Probiotics Antimicrob Proteins; 2023 Feb; 15(1):17-29. PubMed ID: 34837166
[TBL] [Abstract][Full Text] [Related]
16. Identification of bioactive molecule from
Tripathi MK; Singh P; Sharma S; Singh TP; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2021 Sep; 39(15):5668-5681. PubMed ID: 32643552
[TBL] [Abstract][Full Text] [Related]
17. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
[TBL] [Abstract][Full Text] [Related]
18. Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS-CoV-2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals.
Husain I; Ahmad R; Siddiqui S; Chandra A; Misra A; Srivastava A; Ahamad T; Khan MF; Siddiqi Z; Trivedi A; Upadhyay S; Gupta A; Srivastava AN; Ahmad B; Mehrotra S; Kant S; Mahdi AA; Mahdi F
J Food Biochem; 2022 Oct; 46(10):e14262. PubMed ID: 35796388
[TBL] [Abstract][Full Text] [Related]
19. Silybin B and Cianidanol Inhibit M
Srivastava R; Tripathi S; Unni S; Hussain A; Haque S; Dasgupta N; Singh V; Mishra BN
Curr Pharm Des; 2021; 27(32):3476-3489. PubMed ID: 33302853
[TBL] [Abstract][Full Text] [Related]
20. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
Swain SS; Singh SR; Sahoo A; Hussain T; Pati S
J Biomol Struct Dyn; 2022 Sep; 40(14):6463-6476. PubMed ID: 33583350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
